Isoflavones made simple - Genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits

Medical Hypotheses

Volumn 66, Issue 6, 2006, Pages 1093-1114

  McCarty, Mark Frederick ^a  

^a Natural Alternatives International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHANIN A; DAIDZEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ESTROGEN; ESTROGEN RECEPTOR; GENISTEIN; ISOFLAVONE DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; BINDING AFFINITY; BONE METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG EFFECT; HEALTH CARE; HORMONE SUBSTITUTION; HUMAN; IN VITRO STUDY; KIDNEY FAILURE; MESANGIUM CELL; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; BONE DISEASES; CARDIOVASCULAR DISEASES; DIET THERAPY; ESTROGEN RECEPTOR BETA; GENISTEIN; HUMANS; KIDNEY DISEASES; MODELS, BIOLOGICAL; PLANT EXTRACTS; SOYBEANS;

BACTERIA (MICROORGANISMS);

EID: 33645213907     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.11.046     Document Type: Article

References (340)

1. G.G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.A. Gustafsson Cloning of a novel receptor expressed in rat prostate and ovary Proc Natl Acad Sci USA 93 1996 5925 5930
2. G.G. Kuiper, and J.A. Gustafsson The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens FEBS Lett 410 1997 87 90
3. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, and S. Nilsson Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 1997 863 870
4. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, and P.T. van der Saag Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 1998 4252 4263
5. T. Barkhem, B. Carlsson, Y. Nilsson, E. Enmark, J. Gustafsson, and S. Nilsson Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists Mol Pharmacol 54 1998 105 112
6. E.J. Routledge, R. White, M.G. Parker, and J.P. Sumpter Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta J Biol Chem 275 2000 35986 35993
7. J. An, C. Tzagarakis-Foster, T.C. Scharschmidt, N. Lomri, and D.C. Leitman Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens J Biol Chem 276 2001 17808 17814
8. K. Morito, T. Hirose, J. Kinjo, T. Hirakawa, M. Okawa, and T. Nohara Interaction of phytoestrogens with estrogen receptors alpha and beta Biol Pharm Bull 24 2001 351 356
9. J. Liu, K.S. Knappenberger, H. Kack, G. Andersson, E. Nilsson, and C. Dartsch A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment Mol Endocrinol 17 2003 346 355
10. R.S. Muthyala, Y.H. Ju, S. Sheng, L.D. Williams, D.R. Doerge, and B.S. Katzenellenbogen Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta Bioorg Med Chem 12 2004 1559 1567
11. T.F. Bovee, R.J. Helsdingen, I.M. Rietjens, J. Keijer, and R.L. Hoogenboom Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types J Steroid Biochem Mol Biol 91 2004 99 109
12. S.O. Mueller, S. Simon, K. Chae, M. Metzler, and K.S. Korach Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells Toxicol Sci 80 2004 14 25
13. D. Kostelac, G. Rechkemmer, and K. Briviba Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element J Agric Food Chem 51 2003 7632 7635
14. S. Kurebayashi, Y. Miyashita, T. Hirose, S. Kasayama, S. Akira, and T. Kishimoto Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor J Steroid Biochem Mol Biol 60 1997 11 17
15. K. Paech, P. Webb, G.G. Kuiper, S. Nilsson, J. Gustafsson, and P.J. Kushner Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites Science 277 1997 1508 1510
16. B. Saville, M. Wormke, F. Wang, T. Nguyen, E. Enmark, and G. Kuiper Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements J Biol Chem 275 2000 5379 5387
17. M. Sabbah, D. Courilleau, J. Mester, and G. Redeuilh Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element Proc Natl Acad Sci USA 96 1999 11217 11222
18. P.J. Kushner, D.A. Agard, G.L. Greene, T.S. Scanlan, A.K. Shiau, and R.M. Uht Estrogen receptor pathways to AP-1 J Steroid Biochem Mol Biol 74 2000 311 317
19. J.J. Wu, E. Geimonen, and J. Andersen Increased expression of estrogen receptor beta in human uterine smooth muscle at term Eur J Endocrinol 142 2000 92 99
20. S. Maruyama, N. Fujimoto, K. Asano, and A. Ito Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha J Steroid Biochem Mol Biol 78 2001 177 184
21. M.M. Liu, C. Albanese, C.M. Anderson, K. Hilty, P. Webb, and R.M. Uht Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression J Biol Chem 277 2002 24353 24360
22. N. Kanda, and S. Watanabe 17Beta-estradiol inhibits MCP-1 production in human keratinocytes J Invest Dermatol 120 2003 1058 1066
23. H. Adlercreutz, H. Markkanen, and S. Watanabe Plasma concentrations of phyto-oestrogens in Japanese men Lancet 342 1993 1209 1210
24. H. Adlercreutz, T. Fotsis, J. Lampe, K. Wahala, T. Makela, and G. Brunow Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry Scand J Clin Lab Invest Suppl 215 1993 5 18
25. K.D. Setchell, N.M. Brown, P. Desai, L. Zimmer-Nechemias, B.E. Wolfe, and W.T. Brashear Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements J Nutr 131 2001 1362S 1375S
26. N. Morabito, A. Crisafulli, C. Vergara, A. Gaudio, A. Lasco, and N. Frisina Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study J Bone Miner Res 17 2002 1904 1912
27. O. Lapcik, R. Hampl, M. Hill, K. Wahala, N.A. Maharik, and H. Adlercreutz Radioimmunoassay of free genistein in human serum J Steroid Biochem Mol Biol 64 1998 261 268
28. S.C. Nagel, F.S. vom Saal, and W.V. Welshons The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity Proc Soc Exp Biol Med 217 1998 300 309
29. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, and N. Itoh Genistein, a specific inhibitor of tyrosine-specific protein kinases J Biol Chem 262 1987 5592 5595
30. J. Markovits, C. Linassier, P. Fosse, J. Couprie, J. Pierre, and A. Jacquemin-Sablon Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II Cancer Res 49 1989 5111 5117
31. M. Suetsugi, L. Su, K. Karlsberg, Y.C. Yuan, and S. Chen Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors Mol Cancer Res 1 2003 981 991
32. C.Y. Pau, K.Y. Pau, and H.G. Spies Putative estrogen receptor beta and alpha mRNA expression in male and female rhesus macaques Mol Cell Endocrinol 146 1998 59 68
33. D. Alvaro, G. Alpini, P. Onori, L. Perego, B.G. Svegliata, and A. Franchitto Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats Gastroenterology 119 2000 1681 1691
34. A.H. Taylor, and F. Al Azzawi Immunolocalisation of oestrogen receptor beta in human tissues J Mol Endocrinol 24 2000 145 155
35. G. Pelletier Localization of androgen and estrogen receptors in rat and primate tissues Histol Histopathol 15 2000 1261 1270
36. A. Hillisch, O. Peters, D. Kosemund, G. Muller, A. Walter, and B. Schneider Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design Mol Endocrinol 18 2004 1599 1609
37. S. Vehkavaara, A. Silveira, T. Hakala-Ala-Pietila, A. Virkamaki, O. Hovatta, and A. Hamsten Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women Thromb Haemost 85 2001 619 625
38. M. Hemelaar, M.J. van der Mooren, V. Mijatovic, A.A. Bouman, C.P. Schijf, and M.V. Kroeks Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study Menopause 10 2003 550 558
39. S. Nanda, N. Gupta, H.C. Mehta, and K. Sangwan Effect of oestrogen replacement therapy on serum lipid profile Aust N Z J Obstet Gynaecol 43 2003 213 216
40. H. Schunkert, A.H. Danser, H.W. Hense, F.H. Derkx, S. Kurzinger, and G.A. Riegger Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women Circulation 95 1997 39 45
41. S.I. Helle, I.H. Omsjo, S.C. Hughes, L. Botta, G. Huls, and J.M. Holly Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study Clin Endocrinol (Oxf) 45 1996 727 732
42. M. Paassilta, A. Karjalainen, K. Kervinen, M.J. Savolainen, J. Heikkinen, and A.C. Backstrom Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels Atherosclerosis 149 2000 157 162
43. H.J. Cardim, C.M. Lopes, D. Giannella-Neto, A.M. da Fonseca, and J.A. Pinotti The insulin-like growth factor-I system and hormone replacement therapy Fertil Steril 75 2001 282 287
44. N. Biglia, S. Ambroggio, R. Ponzone, L. Sgro, E. Ujcic, and F.A. Dato Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens Maturitas 45 2003 283 291
45. P.Y. Scarabin, M. Alhenc-Gelas, Plu-Bureau, P. Taisne, R. Agher, and M. Aiach Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial Arterioscler Thromb Vasc Biol 17 1997 3071 3078
46. G.D. Lowe, M.N. Upton, A. Rumley, A. McConnachie, D.S. O'Reilly, and G.C. Watt Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein-a cross-sectional population survey Thromb Haemost 86 2001 550 556
47. G.D. Lowe Hormone replacement therapy: prothrombotic vs. protective effects Pathophysiol Haemost Thromb 32 2002 329 332
48. M.S. Post, M. Christella, L.G. Thomassen, M.J. van der Mooren, W.M. van Baal, and J. Rosing Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women Arterioscler Thromb Vasc Biol 23 2003 1116 1121
49. E. Oger, M. Alhenc-Gelas, K. Lacut, M.T. Blouch, N. Roudaut, and V. Kerlan Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial Arterioscler Thromb Vasc Biol 23 2003 1671 1676
50. P.Y. Scarabin, E. Oger, and Plu-Bureau Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk Lancet 362 2003 428 432
51. K.A. Greaves, J.S. Parks, J.K. Williams, and J.D. Wagner Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys J Nutr 129 1999 1585 1592
52. A.H. Lichtenstein, S.M. Jalbert, H. Adlercreutz, B.R. Goldin, H. Rasmussen, and E.J. Schaefer Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects Arterioscler Thromb Vasc Biol 22 2002 1852 1858
53. R.M. Weggemans, and E.A. Trautwein Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis Eur J Clin Nutr 57 2003 940 946
54. I. Demonty, B. Lamarche, and P.J. Jones Role of isoflavones in the hypocholesterolemic effect of soy Nutr Rev 61 2003 189 203
55. K.F. Adams, K.M. Newton, C. Chen, S.S. Emerson, J.D. Potter, and E. White Soy isoflavones do not modulate circulating insulin-like growth factor concentrations in an older population in an intervention trial J Nutr 133 2003 1316 1319
56. H.J. Teede, F.S. Dalais, and B.P. McGrath Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women Am J Clin Nutr 79 2004 396 401
57. H.H. Wang, N.H. Afdhal, and D.Q. Wang Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones Gastroenterology 127 2004 239 249
58. K.K. Carroll Hypercholesterolemia and atherosclerosis: effects of dietary protein Fed Proc 41 1982 2792 2796
59. C.R. Sirtori, E. Gianazza, C. Manzoni, M.R. Lovati, and P.A. Murphy Role of isoflavones in the cholesterol reduction by soy proteins in the clinic Am J Clin Nutr 65 1997 166 167
60. C.R. Sirtori, E. Agradi, F. Conti, O. Mantero, and E. Gatti Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia Lancet 1 1977 275 277
61. J.W. Anderson, B.M. Johnstone, and M.E. Cook-Newell Meta-analysis of the effects of soy protein intake on serum lipids [see comments] N Engl J Med 333 1995 276 282
62. S.H. Shah, and K.P. Alexander Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease Curr Treat Options Cardiovasc Med 5 2003 25 33
63. J.F. Couse, and K.S. Korach Contrasting phenotypes in reproductive tissues of female estrogen receptor null mice Ann N Y Acad Sci 948 2001 1 8
64. A.M. Duncan, K.E. Underhill, X. Xu, J. Lavalleur, W.R. Phipps, and M.S. Kurzer Modest hormonal effects of soy isoflavones in postmenopausal women J Clin Endocrinol Metab 84 1999 3479 3484
65. M.S. Kurzer Hormonal effects of soy in premenopausal women and men J Nutr 132 2002 570S 573S
66. J.L. Balk, D.A. Whiteside, G. Naus, E. DeFerrari, and J.M. Roberts A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium J Soc Gynecol Investig 9 2002 238 242
67. M. Penotti, E. Fabio, A.B. Modena, M. Rinaldi, U. Omodei, and P. Vigano Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries Fertil Steril 79 2003 1112 1117
68. A. Sammartino, C. Di Carlo, V.D. Mandato, G. Bifulco, M. Di Stefano, and C. Nappi Effects of genistein on the endometrium: ultrasonographic evaluation Gynecol Endocrinol 17 2003 45 49
69. M.J. Murray, W.R. Meyer, B.A. Lessey, R.H. Oi, R.E. DeWire, and M.A. Fritz Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial Menopause 10 2003 456 464
70. R.C. Santell, Y.C. Chang, M.G. Nair, and W.G. Helferich Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats J Nutr 127 1997 263 269
71. K.L. Chambliss, and P.W. Shaul Estrogen modulation of endothelial nitric oxide synthase Endocr Rev 23 2002 665 686
72. A.M. McNeill, N. Kim, S.P. Duckles, D.N. Krause, and H.A. Kontos Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels Stroke 30 1999 2186 2190
73. S. Yang, L. Bae, and L. Zhang Estrogen increases eNOS and NOx release in human coronary artery endothelium J Cardiovasc Pharmacol 36 2000 242 247
74. C. Stirone, Y. Chu, L. Sunday, S.P. Duckles, and D.N. Krause 17 Beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction Eur J Pharmacol 478 2003 35 38
75. M.P. Haynes, L. Li, D. Sinha, K.S. Russell, K. Hisamoto, and R. Baron Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen J Biol Chem 278 2003 2118 2123
76. K.L. Chambliss, I.S. Yuhanna, R.G. Anderson, M.E. Mendelsohn, and P.W. Shaul ERbeta has nongenomic action in caveolae Mol Endocrinol 16 2002 938 946
77. A.H. Wagner, M.R. Schroeter, and M. Hecker 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells FASEB J 15 2001 2121 2130
78. M.J. Evans, H.A. Harris, C.P. Miller, S.K. Karathanasis, and S.J. Adelman Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways Endocrinology 143 2002 3785 3795
79. G.M. Rubanyi, A.D. Freay, K. Kauser, D. Sukovich, G. Burton, and D.B. Lubahn Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption J Clin Invest 99 1997 2429 2437
80. E. Tan, M.V. Gurjar, R.V. Sharma, and R.C. Bhalla Estrogen receptor-alpha gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration Cardiovasc Res 43 1999 788 797
81. G.G. Geary, A.M. McNeill, J.A. Ospina, D.N. Krause, K.S. Korach, and S.P. Duckles Selected contribution: cerebrovascular nos and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alpha J Appl Physiol 91 2001 2391 2399
82. G.M. Rubanyi, K. Kauser, and A. Johns Role of estrogen receptors in the vascular system Vascul Pharmacol 38 2002 81 88
83. B. Darblade, C. Pendaries, A. Krust, S. Dupont, M.J. Fouque, and J. Rami Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor Circ Res 90 2002 413 419
84. J. Widder, T. Pelzer, C. Poser-Klein, K. Hu, V. Jazbutyte, and K.H. Fritzemeier Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR Hypertension 42 2003 991 996
85. J.M. Muller-Delp, D.B. Lubahn, K.E. Nichol, B.J. Philips, E.M. Price, and E.M. Curran Regulation of nitric oxide-dependent vasodilation in coronary arteries of estrogen receptor-alpha-deficient mice Am J Physiol Heart Circ Physiol 285 2003 H2150 H2157
86. S. Nuedling, R.H. Karas, M.E. Mendelsohn, J.A. Katzenellenbogen, B.S. Katzenellenbogen, and R. Meyer Activation of estrogen receptor beta is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes FEBS Lett 502 2001 103 108
87. K. Kakui, H. Itoh, N. Sagawa, S. Yura, D. Korita, and M. Takemura Augmented endothelial nitric oxide synthase (eNOS) protein expression in human pregnant myometrium: possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER)alpha and ERbeta Mol Hum Reprod 10 2004 115 122
88. Y. Zhu, Z. Bian, P. Lu, R.H. Karas, L. Bao, and D. Cox Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta Science 295 2002 505 508
89. S. Makela, H. Savolainen, E. Aavik, M. Myllarniemi, L. Strauss, and E. Taskinen Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta Proc Natl Acad Sci USA 96 1999 7077 7082
90. F. Squadrito, D. Altavilla, N. Morabito, A. Crisafulli, R. D'Anna, and F. Corrado The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women Atherosclerosis 163 2002 339 347
91. F. Squadrito, D. Altavilla, A. Crisafulli, A. Saitta, D. Cucinotta, and N. Morabito Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study Am J Med 114 2003 470 476
92. F.M. Steinberg, N.L. Guthrie, A.C. Villablanca, K. Kumar, and M.J. Murray Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women Am J Clin Nutr 78 2003 123 130
93. L.W. Lissin, R. Oka, S. Lakshmi, and J.P. Cooke Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia Vasc Med 9 2004 26 30
94. P.M. Vanhoutte Say NO to ET J Auton Nerv Syst 81 2000 271 277
95. L.A. Simons, M. Von Konigsmark, J. Simons, and D.S. Celermajer Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women Am J Cardiol 85 2000 1297 1301
96. G. Hale, M. Paul-Labrador, J.H. Dwyer, and C.N. Merz Isoflavone supplementation and endothelial function in menopausal women Clin Endocrinol (Oxf) 56 2002 693 701
97. P.J. Nestel, T. Yamashita, T. Sasahara, S. Pomeroy, A. Dart, and P. Komesaroff Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women Arterioscler Thromb Vasc Biol 17 1997 3392 3398
98. F. Squadrito, D. Altavilla, G. Squadrito, A. Saitta, D. Cucinotta, and L. Minutoli Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats Cardiovasc Res 45 2000 454 462
99. M.A. Catania, A. Crupi, F. Firenzuoli, A. Parisi, A. Sturiale, and F. Squadrito Oral administration of a soy extract improves endothelial dysfunction in ovariectomized rats Planta Med 68 2002 1142 1144
100. S. Khemapech, K. Monsiri, S. Patumraj, and P. Siriviriyakul Genistein replacement therapy for vasodilation disorder in bilateral ovariectomized rats Clin Hemorheol Microcirc 29 2003 271 277
101. T. Izumi, M.K. Piskula, S. Osawa, A. Obata, K. Tobe, and M. Saito Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans J Nutr 130 2000 1695 1699
102. M. Richelle, S. Pridmore-Merten, S. Bodenstab, M. Enslen, and E.A. Offord Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women J Nutr 132 2002 2587 2592
103. L. Zubik, and M. Meydani Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women Am J Clin Nutr 77 2003 1459 1465
104. K.D. Setchell, N.M. Brown, L. Zimmer-Nechemias, W.T. Brashear, B.E. Wolfe, and A.S. Kirschner Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability Am J Clin Nutr 76 2002 447 453
105. A.J. Day, M.S. DuPont, S. Ridley, M. Rhodes, M.J. Rhodes, and M.R. Morgan Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity FEBS Lett 436 1998 71 75
106. K. Murota, S. Shimizu, S. Miyamoto, T. Izumi, A. Obata, and M. Kikuchi Unique uptake and transport of isoflavone aglycones by human intestinal caco-2 cells: comparison of isoflavonoids and flavonoids J Nutr 132 2002 1956 1961
107. X. Xu, K.S. Harris, H.J. Wang, P.A. Murphy, and S. Hendrich Bioavailability of soybean isoflavones depends upon gut microflora in women J Nutr 125 1995 2307 2315
108. H.A. Walker, T.S. Dean, T.A. Sanders, G. Jackson, J.M. Ritter, and P.J. Chowienczyk The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol Circulation 103 2001 258 262
109. H.J. Teede, F.S. Dalais, D. Kotsopoulos, Y.L. Liang, S. Davis, and B.P. McGrath Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women J Clin Endocrinol Metab 86 2001 3053 3060
110. J.A. McCrohon, W.A. Walters, J.T. Robinson, R.J. McCredie, L. Turner, and M.R. Adams Arterial reactivity is enhanced in genetic males taking high dose estrogens J Am Coll Cardiol 29 1997 1432 1436
111. G. New, S.J. Duffy, R.W. Harper, and I.T. Meredith Long-term oestrogen therapy is associated with improved endothelium-dependent vasodilation in the forearm resistance circulation of biological males Clin Exp Pharmacol Physiol 27 2000 25 33
112. M.A. Sader, R.J. McCredie, K.A. Griffiths, S.M. Wishart, D.J. Handelsman, and D.S. Celermajer Oestradiol improves arterial endothelial function in healthy men receiving testosterone Clin Endocrinol (Oxf) 54 2001 175 181
113. M. Kimura, K. Sudhir, M. Jones, E. Simpson, A.M. Jefferis, and J.P. Chin-Dusting Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males Circ Res 93 2003 1267 1271
114. H. Hanke, S. Hanke, O. Ickrath, K. Lange, B. Bruck, and A.O. Muck Estradiol concentrations in premenopausal women with coronary heart disease Coron Artery Dis 8 1997 511 515
115. R.C. Christian, S. Harrington, W.D. Edwards, A.L. Oberg, and L.A. Fitzpatrick Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women J Clin Endocrinol Metab 87 2002 1062 1067
116. C.N. Bairey Merz, B.D. Johnson, B.L. Sharaf, V. Bittner, S.L. Berga, and G.D. Braunstein Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study J Am Coll Cardiol 41 2003 413 419
117. J. Vasquez-Vivar, B. Kalyanaraman, P. Martasek, N. Hogg, B.S. Masters, and H. Karoui Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors Proc Natl Acad Sci USA 95 1998 9220 9225
118. S. Milstien, and Z. Katusic Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function Biochem Biophys Res Commun 263 1999 681 684
119. J. Vasquez-Vivar, B. Kalyanaraman, and P. Martasek The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications Free Radic Res 37 2003 121 127
120. E.S. Stroes, E.E. van Faassen, M. Yo, P. Martasek, P. Boer, and R. Govers Folic acid reverts dysfunction of endothelial nitric oxide synthase Circ Res 86 2000 1129 1134
121. M.C. Verhaar, E. Stroes, and T.J. Rabelink Folates and cardiovascular disease Arterioscler Thromb Vasc Biol 22 2002 6 13
122. M.E. Hyndman, S. Verma, R.J. Rosenfeld, T.J. Anderson, and H.G. Parsons Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function Am J Physiol Heart Circ Physiol 282 2002 H2167 H2172
123. S.N. Doshi, I.F. McDowell, S.J. Moat, N. Payne, H.J. Durrant, and M.J. Lewis Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering Circulation 105 2002 22 26
124. M.F. McCarty Coping with endothelial superoxide: potential complementarity of arginine and high-dose folate Med Hypotheses 63 2004 709 718
125. J.P. Cooke, and R.K. Oka Atherogenesis and the arginine hypothesis Curr Atheroscler Rep 3 2001 252 259
126. R.H. Boger The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor Cardiovasc Res 59 2003 824 833
127. O. Vidal, L.G. Kindblom, and C. Ohlsson Expression and localization of estrogen receptor-beta in murine and human bone J Bone Miner Res 14 1999 923 929
128. S. Bord, A. Horner, S. Beavan, and J. Compston Estrogen receptors alpha and beta are differentially expressed in developing human bone J Clin Endocrinol Metab 86 2001 2309 2314
129. G.S. Batra, L. Hainey, A.J. Freemont, G. Andrew, P.T. Saunders, and J.A. Hoyland Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) alpha and beta in bone fractures from men and women J Pathol 200 2003 65 73
130. D.G. Monroe, B.J. Getz, S.A. Johnsen, B.L. Riggs, S. Khosla, and T.C. Spelsberg Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta J Cell Biochem 90 2003 315 326
131. M.K. Lindberg, S. Moverare, S. Skrtic, H. Gao, K. Dahlman-Wright, and J.A. Gustafsson Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice Mol Endocrinol 17 2003 203 208
132. S.H. Windahl, K. Hollberg, O. Vidal, J.A. Gustafsson, C. Ohlsson, and G. Andersson Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss J Bone Miner Res 16 2001 1388 1398
133. N.A. Sims, P. Clement-Lacroix, D. Minet, C. Fraslon-Vanhulle, M. Gaillard-Kelly, and M. Resche-Rigon A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice J Clin Invest 111 2003 1319 1327
134. N.A. Sims, S. Dupont, A. Krust, P. Clement-Lacroix, D. Minet, and M. Resche-Rigon Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males Bone 30 2002 18 25
135. L. Cao, R. Bu, J.I. Oakley, S.E. Kalla, and H.C. Blair Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells J Cell Biochem 89 2003 152 164
136. S. Koka, T.M. Petro, and R.A. Reinhardt Estrogen inhibits interleukin-1beta-induced interleukin-6 production by human osteoblast-like cells J Interferon Cytokine Res 18 1998 479 483
137. S. Bord, D.C. Ireland, S.R. Beavan, and J.E. Compston The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts Bone 32 2003 136 141
138. X. Chen, S.C. Garner, L.D. Quarles, and J.J. Anderson Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation J Nutr Biochem 14 2003 342 349
139. V. Viereck, C. Grundker, S. Blaschke, H. Siggelkow, G. Emons, and L.C. Hofbauer Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts J Cell Biochem 84 2002 725 735
140. J. Aguirre, L. Buttery, M. O'Shaughnessy, F. Afzal, I. Fernandez de Marticorena, and M. Hukkanen Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity Am J Pathol 158 2001 247 257
141. A. Samuels, M.J. Perry, R.L. Gibson, S. Colley, and J.H. Tobias Role of endothelial nitric oxide synthase in estrogen-induced osteogenesis Bone 29 2001 24 29
142. S.I. McFarlane, R. Muniyappa, J.J. Shin, G. Bahtiyar, and J.R. Sowers Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23 2004 1 10
143. J.J. Anderson, W.W. Ambrose, and S.C. Garner Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model Proc Soc Exp Biol Med 217 1998 345 350
144. P. Fanti, M.C. Monier-Faugere, Z. Geng, J. Schmidt, P.E. Morris, and D. Cohen The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats Osteoporos Int 8 1998 274 281
145. Y. Ishimi, C. Miyaura, M. Ohmura, Y. Onoe, T. Sato, and Y. Uchiyama Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency Endocrinology 140 1999 1893 1900
146. J. Wu, X.X. Wang, M. Takasaki, A. Ohta, M. Higuchi, and Y. Ishimi Cooperative effects of exercise training and genistein administration on bone mass in ovariectomized mice J Bone Miner Res 16 2001 1829 1836
147. D. Nakajima, C.S. Kim, T.W. Oh, C.Y. Yang, T. Naka, and S. Igawa Suppressive effects of genistein dosage and resistance exercise on bone loss in ovariectomized rats J Physiol Anthropol Appl Human Sci 20 2001 285 291
148. B. Li, and S. Yu Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation Biol Pharm Bull 26 2003 780 786
149. H.A. Harris, L.M. Albert, Y. Leathurby, M.S. Malamas, R.E. Mewshaw, and C.P. Miller Evaluation of an estrogen receptor-beta agonist in animal models of human disease Endocrinology 144 2003 4241 4249
150. S.M. Potter, J.A. Baum, H. Teng, R.J. Stillman, N.F. Shay, and J.W. Erdman Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women Am J Clin Nutr 68 1998 1375S 1379S
151. T. Uesugi, Y. Fukui, and Y. Yamori Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japanese women: a four-week study J Am Coll Nutr 21 2002 97 102
152. Y. Yamori, E.H. Moriguchi, T. Teramoto, A. Miura, Y. Fukui, and K.I.
153. Y.M. Chen, S.C. Ho, S.S. Lam, S.S. Ho, and J.L. Woo Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial J Clin Endocrinol Metab 88 2003 4740 4747
154. Y.M. Chen, S.C. Ho, S.S. Lam, S.S. Ho, and J.L. Woo Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial Menopause 11 2004 246 254
155. A. Crisafulli, D. Altavilla, G. Squadrito, A. Romeo, E.B. Adamo, and R. Marini Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women J Clin Endocrinol Metab 89 2004 188 192
156. C.S. Hsu, W.W. Shen, Y.M. Hsueh, and S.L. Yeh Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density J Reprod Med 46 2001 221 226
157. J.C. Gallagher, R. Satpathy, K. Rafferty, and V. Haynatzka The effect of soy protein isolate on bone metabolism Menopause 11 2004 290 298
158. S. Kreijkamp-Kaspers, L. Kok, D.E. Grobbee, E.H. de Haan, A. Aleman, and J.W. Lampe Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial JAMA 292 2004 65 74
159. J.J. Anderson, X. Chen, A. Boass, M. Symons, M. Kohlmeier, and J.B. Renner Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year J Am Coll Nutr 21 2002 388 393
160. D.A. Khalil, E.A. Lucas, S. Juma, B.J. Smith, M.E. Payton, and B.H. Arjmandi Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism J Nutr 132 2002 2605 2608
161. Y. Somekawa, M. Chiguchi, T. Ishibashi, and T. Aso Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women Obstet Gynecol 97 2001 109 115
162. S.C. Ho, J. Woo, S. Lam, Y. Chen, A. Sham, and J. Lau Soy protein consumption and bone mass in early postmenopausal Chinese women Osteoporos Int 14 2003 835 842
163. A.F. Kardinaal, M.S. Morton, I.E. Bruggemann-Rotgans, and E.C. van Beresteijn Phyto-oestrogen excretion and rate of bone loss in postmenopausal women Eur J Clin Nutr 52 1998 850 855
164. M.K. Kim, B.C. Chung, V.Y. Yu, J.H. Nam, H.C. Lee, and K.B. Huh Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women Clin Endocrinol (Oxf) 56 2002 321 328
165. C. Nagata, H. Shimizu, R. Takami, M. Hayashi, N. Takeda, and K. Yasuda Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women Osteoporos Int 13 2002 200 204
166. D. Kritz-Silverstein, and D.L. Goodman-Gruen Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women J Womens Health Gend Based Med 11 2002 69 78
167. M. Royuela, M.P. de Miguel, F.R. Bethencourt, M. Sanchez-Chapado, B. Fraile, and M.I. Arenas Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate J Endocrinol 168 2001 447 454
168. T. Fixemer, K. Remberger, and H. Bonkhoff Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma Prostate 54 2003 79 87
169. S. Signoretti, and M. Loda Estrogen receptor beta in prostate cancer: brake pedal or accelerator? Am J Pathol 159 2001 13 16
170. S.M. Ho Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates J Cell Biochem 91 2004 491 503
171. J.H. Krege, J.B. Hodgin, J.F. Couse, E. Enmark, M. Warner, and J.F. Mahler Generation and reproductive phenotypes of mice lacking estrogen receptor beta Proc Natl Acad Sci USA 95 1998 15677 15682
172. Z. Weihua, S. Makela, L.C. Andersson, S. Salmi, S. Saji, and J.I. Webster A role for estrogen receptor beta in the regulation of growth of the ventral prostate Proc Natl Acad Sci USA 98 2001 6330 6335
173. J. Cheng, E.J. Lee, L.D. Madison, and G. Lazennec Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis FEBS Lett 566 2004 169 172
174. X. Zhu, I. Leav, Y.K. Leung, M. Wu, Q. Liu, and Y. Gao Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis Am J Pathol 164 2004 2003 2012
175. M.J. Linja, K.J. Savinainen, T.L. Tammela, J.J. Isola, and T. Visakorpi Expression of ERalpha and ERbeta in prostate cancer Prostate 55 2003 180 186
176. K.M. Lau, M. LaSpina, J. Long, and S.M. Ho Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation Cancer Res 60 2000 3175 3182
177. I.Y. Kim, d.H. Seong, B.C. Kim, D.K. Lee, A.T. Remaley, and F. Leach Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway Cancer Res 62 2002 3649 3653
178. I.Y. Kim, B.C. Kim, d.H. Seong, D.K. Lee, J.M. Seo, and Y.J. Hong Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines Cancer Res 62 2002 5365 5369
179. D.L. Bemis, J.L. Capodice, M. Desai, R. Buttyan, and A.E. Katz A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo Clin Cancer Res 10 2004 5282 5292
180. J. Bektic, A.P. Berger, K. Pfeil, G. Dobler, G. Bartsch, and H. Klocker Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta Eur Urol 45 2004 245 251
181. J.R. Zhou, E.T. Gugger, T. Tanaka, Y. Guo, G.L. Blackburn, and S.K. Clinton Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice J Nutr 129 1999 1628 1635
182. W.J. Aronson, C.N. Tymchuk, R.M. Elashoff, W.H. McBride, C. McLean, and H. Wang Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones Nutr Cancer 35 1999 130 136
183. W.A. Fritz, J. Wang, I.E. Eltoum, and C.A. Lamartiniere Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate Mol Cell Endocrinol 186 2002 89 99
184. J. Wang, I.E. Eltoum, and C.A. Lamartiniere Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats Cancer Lett 186 2002 11 18
185. R. Mentor-Marcel, C.A. Lamartiniere, I.E. Eltoum, N.M. Greenberg, and A. Elgavish Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP) Cancer Res 61 2001 6777 6782
186. M. Hussain, M. Banerjee, F.H. Sarkar, Z. Djuric, M.N. Pollak, and D. Doerge Soy isoflavones in the treatment of prostate cancer Nutr Cancer 47 2003 111 117
187. R.W. deVere White, R.M. Hackman, S.E. Soares, L.A. Beckett, Y. Li, and B. Sun Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer Urology 63 2004 259 263
188. M.J. Messina Emerging evidence on the role of soy in reducing prostate cancer risk Nutr Rev 61 2003 117 131
189. M.M. Lee, S.L. Gomez, J.S. Chang, M. Wey, R.T. Wang, and A.W. Hsing Soy and isoflavone consumption in relation to prostate cancer risk in China Cancer Epidemiol Biomarkers Prev 12 2003 665 668
190. K. Ozasa, M. Nakao, Y. Watanabe, K. Hayashi, T. Miki, and K. Mikami Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men Cancer Sci 95 2004 65 71
191. G. Pelletier, and M. El Alfy Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs J Clin Endocrinol Metab 85 2000 4835 4840
192. C. Palmieri, S. Saji, H. Sakaguchi, G. Cheng, A. Sunters, and M.J. O'Hare The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts J Mol Endocrinol 33 2004 35 50
193. J.F. Couse, and K.S. Korach Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20 1999 358 417
194. J.A. Gustafsson, and M. Warner Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer J Steroid Biochem Mol Biol 74 2000 245 248
195. S. Paruthiyil, H. Parmar, V. Kerekatte, G.R. Cunha, G.L. Firestone, and D.C. Leitman Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest Cancer Res 64 2004 423 428
196. A. Strom, J. Hartman, J.S. Foster, S. Kietz, J. Wimalasena, and J.A. Gustafsson Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D Proc Natl Acad Sci USA 101 2004 1566 1571
197. Y.F. Hou, S.T. Yuan, H.C. Li, J. Wu, J.S. Lu, and G. Liu ERbeta exerts multiple stimulative effects on human breast carcinoma cells Oncogene 23 2004 5799 5806
198. H. Dotzlaw, E. Leygue, P.H. Watson, and L.C. Murphy Expression of estrogen receptor-beta in human breast tumors J Clin Endocrinol Metab 82 1997 2371 2374
199. S.A. Fuqua, R. Schiff, I. Parra, J.T. Moore, S.K. Mohsin, and C.K. Osborne Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters Cancer Res 63 2003 2434 2439
200. W.B. Murrill, N.M. Brown, J.X. Zhang, P.A. Manzolillo, S. Barnes, and C.A. Lamartiniere Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats Carcinogenesis 17 1996 1451 1457
201. C.A. Lamartiniere, W.B. Murrill, P.A. Manzolillo, J.X. Zhang, S. Barnes, and X. Zhang Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats Proc Soc Exp Biol Med 217 1998 358 364
202. A. Cabanes, M. Wang, S. Olivo, S. DeAssis, J.A. Gustafsson, and G. Khan Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis Carcinogenesis 25 2004 741 748
203. Z. Jin, and R.S. MacDonald Soy isoflavones increase latency of spontaneous mammary tumors in mice J Nutr 132 2002 3186 3190
204. L. Yuan, C. Wagatsuma, M. Yoshida, T. Miura, T. Mukoda, and H. Fujii Inhibition of human breast cancer growth by GCP (genistein combined polysaccharide) in xenogeneic athymic mice: involvement of genistein biotransformation by beta-glucuronidase from tumor tissues Mutat Res 523-524 2003 55 62
205. H. Mizunuma, K. Kanazawa, S. Ogura, S. Otsuka, and H. Nagai Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer Oncology 62 2002 78 84
206. C.Y. Hsieh, R.C. Santell, S.Z. Haslam, and W.G. Helferich Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo Cancer Res 58 1998 3833 3838
207. C.D. Allred, K.F. Allred, Y.H. Ju, S.M. Virant, and W.G. Helferich Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner Cancer Res 61 2001 5045 5050
208. Y.H. Ju, C.D. Allred, K.F. Allred, K.L. Karko, D.R. Doerge, and W.G. Helferich Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice J Nutr 131 2001 2957 2962
209. Y.H. Ju, D.R. Doerge, K.F. Allred, C.D. Allred, and W.G. Helferich Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice Cancer Res 62 2002 2474 2477
210. M. Maggiolini, D. Bonofiglio, S. Marsico, M.L. Panno, B. Cenni, and D. Picard Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells Mol Pharmacol 60 2001 595 602
211. C.D. Allred, K.F. Allred, Y.H. Ju, L.M. Clausen, D.R. Doerge, and S.L. Schantz Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats Carcinogenesis 25 2004 211 218
212. J.K. Day, C. Besch-Williford, T.R. McMann, M.G. Hufford, D.B. Lubahn, and R.S. MacDonald Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice Nutr Cancer 39 2001 226 232
213. T. Hirohata, T. Shigematsu, A.M. Nomura, Y. Nomura, A. Horie, and I. Hirohata Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan Natl Cancer Inst Monogr 69 1985 187 190
214. J.M. Yuan, Q.S. Wang, R.K. Ross, B.E. Henderson, and M.C. Yu Diet and breast cancer in Shanghai and Tianjin, China Br J Cancer 71 1995 1353 1358
215. T.J. Key, G.B. Sharp, P.N. Appleby, V. Beral, M.T. Goodman, and M. Soda Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan Br J Cancer 81 1999 1248 1256
216. P.L. Horn-Ross, E.M. John, M. Lee, S.L. Stewart, J. Koo, and L.C. Sakoda Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study Am J Epidemiol 154 2001 434 441
217. P.L. Horn-Ross, K.J. Hoggatt, D.W. West, M.R. Krone, S.L. Stewart, and H. Anton Recent diet and breast cancer risk: the California Teachers Study (USA) Cancer Causes Control 13 2002 407 415
218. H.P. Lee, L. Gourley, S.W. Duffy, J. Esteve, J. Lee, and N.E. Day Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore Cancer Causes Control 3 1992 313 322
219. K. Hirose, K. Tajima, N. Hamajima, M. Inoue, T. Takezaki, and T. Kuroishi A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status Jpn J Cancer Res 86 1995 146 154
220. A.H. Wu, R.G. Ziegler, P.L. Horn-Ross, A.M. Nomura, D.W. West, and L.N. Kolonel Tofu and risk of breast cancer in Asian-Americans Cancer Epidemiol Biomarkers Prev 5 1996 901 906
221. Q. Dai, X.O. Shu, F. Jin, J.D. Potter, L.H. Kushi, and J. Teas Population-based case-control study of soyfood intake and breast cancer risk in Shanghai Br J Cancer 85 2001 372 378
222. A.H. Wu, P. Wan, J. Hankin, C.C. Tseng, M.C. Yu, and M.C. Pike Adolescent and adult soy intake and risk of breast cancer in Asian-Americans Carcinogenesis 23 2002 1491 1496
223. S. Yamamoto, T. Sobue, M. Kobayashi, S. Sasaki, and S. Tsugane Soy, isoflavones, and breast cancer risk in Japan J Natl Cancer Inst 95 2003 906 913
224. A.L. Huntley, and E. Ernst Soy for the treatment of perimenopausal symptoms-a systematic review Maturitas 47 2004 1 9
225. A. Crisafulli, H. Marini, A. Bitto, D. Altavilla, G. Squadrito, and A. Romeo Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study Menopause 11 2004 400 404
226. P.J. Shughrue, B. Komm, and I. Merchenthaler The distribution of estrogen receptor-beta mRNA in the rat hypothalamus Steroids 61 1996 678 681
227. F.P. Kruijver, R. Balesar, A.M. Espila, U.A. Unmehopa, and D.F. Swaab Estrogen-receptor-beta distribution in the human hypothalamus: similarities and differences with ER alpha distribution J Comp Neurol 466 2003 251 277
228. M.L. Forsling, I. Kallo, D.E. Hartley, L. Heinze, R. Ladek, and C.W. Coen Oestrogen receptor-beta and neurohypophysial hormones: functional interaction and neuroanatomical localisation Pharmacol Biochem Behav 76 2003 535 542
229. S.R. Silbiger, and J. Neugarten The impact of gender on the progression of chronic renal disease Am J Kidney Dis 25 1995 515 533
230. J. Neugarten, A. Acharya, and S.R. Silbiger Effect of gender on the progression of nondiabetic renal disease: a meta-analysis J Am Soc Nephrol 11 2000 319 329
231. M. Potier, M. Karl, F. Zheng, S.J. Elliot, G.E. Striker, and L.J. Striker Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens Am J Pathol 160 2002 1877 1885
232. J. Neugarten, G. Gallo, S. Silbiger, and B. Kasiske Glomerulosclerosis in aging humans is not influenced by gender Am J Kidney Dis 34 1999 884 888
233. T. Sakemi, H. Toyoshima, Y. Shouno, and F. Morito Estrogen attenuates progressive glomerular injury in hypercholesterolemic male Imai rats Nephron 69 1995 159 165
234. T. Sakemi, N. Ohtsuka, Y. Tomiyoshi, and F. Morito Testosterone does not eliminate the attenuating effect of estrogen on progressive glomerular injury in estrogen-treated hypercholesterolemic male Imai rats Kidney Blood Press Res 20 1997 51 56
235. S. Xiao, D.G. Gillespie, C. Baylis, E.K. Jackson, and R.K. Dubey Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth Hypertension 37 2001 645 650
236. S.J. Elliot, M. Karl, M. Berho, M. Potier, F. Zheng, and B. Leclercq Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice Am J Pathol 162 2003 1441 1448
237. B. Antus, P. Hamar, G. Kokeny, Z. Szollosi, I. Mucsi, and Z. Nemes Estradiol is nephroprotective in the rat remnant kidney Nephrol Dial Transplant 18 2003 54 61
238. M.L. Gross, M. Adamczak, T. Rabe, N.A. Harbi, J. Krtil, and A. Koch Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats J Am Soc Nephrol 15 2004 348 358
239. C. Maric, K. Sandberg, and C. Hinojosa-Laborde Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat J Am Soc Nephrol 15 2004 1546 1556
240. T. Sakemi, N. Ohtsuka, Y. Shouno, and F. Morito Effect of ovariectomy on glomerular injury in hypercholesterolemic female Imai rats Nephron 72 1996 72 78
241. J.A. Joles, H. van Goor, and H.A. Koomans Estrogen induces glomerulosclerosis in analbuminemic rats Kidney Int 53 1998 862 868
242. F.T. Stevenson, C.M. Wheeldon, M.D. Gades, G.A. Kaysen, J.S. Stern, and H. van Goor Estrogen worsens incipient hypertriglyceridemic glomerular injury in the obese Zucker rat Kidney Int 57 2000 1927 1935
243. Y. Tomiyoshi, T. Sakemi, S. Aoki, and M. Miyazono Different effects of castration and estrogen administration on glomerular injury in spontaneously hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats Nephron 92 2002 860 867
244. T. Sakemi, N. Ohtsuka, Y. Shouno, and F. Morito Ovariectomy attenuates proteinuria and glomerular injury in unilaterally nephrectomized female Sprague-Dawley rats Nephron 73 1996 251 257
245. N. Ohtsuka, T. Sakemi, Y. Tomiyoshi, and F. Morito Different effect of estrogen administration from castration on glomerular injury in unilaterally nephrectomized male Sprague-Dawley rats Nephron 77 1997 445 451
246. Y. Ikeda, T. Sakemi, Y. Tomiyoshi, and M. Miyazono Combined therapy with estrogen and testosterone eliminates the aggravating effect of estrogen replacement therapy on glomerular injury in hypercholesterolemic female Imai rats Kidney Blood Press Res 23 2000 27 34
247. R.K. Studer, P.A. Craven, and F.R. DeRubertis Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells Metabolism 46 1997 918 925
248. M. Toyoda, D. Suzuki, M. Honma, G. Uehara, T. Sakai, and T. Umezono High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy Kidney Int 66 2004 1107 1114
249. C. Weigert, U. Sauer, K. Brodbeck, A. Pfeiffer, H.U. Haring, and E.D. Schleicher AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells J Am Soc Nephrol 11 2000 2007 2016
250. D. Koya, M.R. Jirousek, Y.W. Lin, H. Ishii, K. Kuboki, and G.L. King Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats J Clin Invest 100 1997 115 126
251. H. Ishii, H. Tada, and S. Isogai An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells Diabetologia 41 1998 362 364
252. K. Ikehara, H. Tada, K. Kuboki, and T. Inokuchi Role of protein kinase C-angiotensin II pathway for extracellular matrix production in cultured human mesangial cells exposed to high glucose levels Diabetes Res Clin Pract 59 2003 25 30
253. T. Yasuda, S. Kondo, T. Homma, and R.C. Harris Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells J Clin Invest 98 1996 1991 2000
254. M. Hirakata, S. Kaname, U.G. Chung, N. Joki, Y. Hori, and M. Noda Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells Kidney Int 51 1997 1028 1036
255. C. Weigert, K. Brodbeck, K. Klopfer, H.U. Haring, and E.D. Schleicher Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia Diabetologia 45 2002 890 898
256. S. Chen, M.P. Cohen, G.T. Lautenslager, C.W. Shearman, and F.N. Ziyadeh Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells Kidney Int 59 2001 673 681
257. Y.S. Kim, B.C. Kim, C.Y. Song, H.K. Hong, K.C. Moon, and H.S. Lee Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta J Lab Clin Med 138 2001 59 68
258. R.K. Studer, H. Negrete, P.A. Craven, and F.R. DeRubertis Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells Kidney Int 48 1995 422 430
259. Z. Wu, Q. Zhou, Y. Lan, Y. Wang, X. Xu, and H. Jin AP-1 complexes mediate oxidized LDL-induced overproduction of TGF-beta(1) in rat mesangial cells Cell Biochem Funct 22 2004 237 247
260. H.S. Lee, B.C. Kim, H.K. Hong, and Y.S. Kim LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-beta expression Am J Physiol 277 1999 F369 F376
261. L.P. Singh, K. Green, M. Alexander, S. Bassly, and E.D. Crook Hexosamines and TGF-beta1 use similar signaling pathways to mediate matrix protein synthesis in mesangial cells Am J Physiol Renal Physiol 286 2004 F409 F416
262. R.H. Weiss, and A. Ramirez TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C Nephrol Dial Transplant 13 1998 2804 2813
263. H. Tada, and S. Isogai The fibronectin production is increased by thrombospondin via activation of TGF-beta in cultured human mesangial cells Nephron 79 1998 38 43
264. C.E. Runyan, H.W. Schnaper, and A.C. Poncelet Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells Am J Physiol Renal Physiol 285 2003 F413 F422
265. M. Zdunek, S. Silbiger, J. Lei, and J. Neugarten Protein kinase CK2 mediates TGF-beta1-stimulated type IV collagen gene transcription and its reversal by estradiol Kidney Int 60 2001 2097 2108
266. R. Singh, R.H. Song, N. Alavi, A.A. Pegoraro, A.K. Singh, and D.J. Leehey High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1 Exp Nephrol 9 2001 249 257
267. W.H. Baricos, S.L. Cortez, M. Deboisblanc, and S. Xin Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells J Am Soc Nephrol 10 1999 790 795
268. A.C. Poncelet, and H.W. Schnaper Regulation of human mesangial cell collagen expression by transforming growth factor-beta1 Am J Physiol 275 1998 F458 F466
269. H.P. Marti, L. Lee, M. Kashgarian, and D.H. Lovett Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase Am J Pathol 144 1994 82 94
270. C. Xin, S. Ren, B. Kleuser, S. Shabahang, W. Eberhardt, and H. Radeke Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses J Biol Chem 279 2004 35255 35262
271. M. Kaizuka, H. Yamabe, H. Osawa, K. Okumura, and N. Fujimoto Thrombin stimulates synthesis of type IV collagen and tissue inhibitor of metalloproteinases-1 by cultured human mesangial cells J Am Soc Nephrol 10 1999 1516 1523
272. J.B. Kopp, V.M. Factor, M. Mozes, P. Nagy, N. Sanderson, and E.P. Bottinger Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease Lab Invest 74 1996 991 1003
273. S.M. Ali, N.J. Laping, T.A. Fredrickson, L.C. Contino, B. Olson, and K. Anderson Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal disease Pharmacology 57 1998 20 27
274. R. Sharma, A. Khanna, M. Sharma, and V.J. Savin Transforming growth factor-beta1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals Kidney Int 58 2000 131 136
275. M. Fujimoto, Y. Maezawa, K. Yokote, K. Joh, K. Kobayashi, and H. Kawamura Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy Biochem Biophys Res Commun 305 2003 1002 1007
276. A. Benigni, C. Zoja, D. Corna, C. Zatelli, S. Conti, and M. Campana Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat J Am Soc Nephrol 14 2003 1816 1824
277. K. Sharma, Y. Jin, J. Guo, and F.N. Ziyadeh Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice Diabetes 45 1996 522 530
278. F.N. Ziyadeh, B.B. Hoffman, D.C. Han, M.C. Iglesias-de la Cruz, S.W. Hong, and M. Isono Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice Proc Natl Acad Sci USA 97 2000 8015 8020
279. S. Chen, M.C. Iglesias-de la Cruz, B. Jim, S.W. Hong, M. Isono, and F.N. Ziyadeh Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice Biochem Biophys Res Commun 300 2003 16 22
280. M. Potier, S.J. Elliot, I. Tack, O. Lenz, G.E. Striker, and L.J. Striker Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9 J Am Soc Nephrol 12 2001 241 251
281. J. Lei, S. Silbiger, F.N. Ziyadeh, and J. Neugarten Serum-stimulated alpha 1 type IV collagen gene transcription is mediated by TGF-beta and inhibited by estradiol Am J Physiol 274 1998 F252 F258
282. S. Silbiger, J. Lei, F.N. Ziyadeh, and J. Neugarten Estradiol reverses TGF-beta1-stimulated type IV collagen gene transcription in murine mesangial cells Am J Physiol 274 1998 F1113 F1118
283. T. Matsuda, T. Yamamoto, A. Muraguchi, and F. Saatcioglu Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3 J Biol Chem 276 2001 42908 42914
284. R. Derynck, Y. Zhang, and X.H. Feng Smads: transcriptional activators of TGF-beta responses Cell 95 1998 737 740
285. P.A. Craven, R.K. Studer, J. Felder, S. Phillips, and F.R. DeRubertis Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells Diabetes 46 1997 671 681
286. A.J. Williams, F. Baker, and J. Walls Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats Nephron 46 1987 83 90
287. A.J. Williams, and J. Walls Metabolic consequences of differing protein diets in experimental renal disease Eur J Clin Invest 17 1987 117 122
288. K. Iwasaki, C.A. Gleiser, E.J. Masoro, C.A. McMahan, E.J. Seo, and B.P. Yu The influence of dietary protein source on longevity and age-related disease processes of Fischer rats J Gerontol 43 1988 B5 B12
289. H.M. Aukema, and I. Housini Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats Kidney Int 59 2001 52 61
290. M.T. Velasquez, and S.J. Bhathena Dietary phytoestrogens: a possible role in renal disease protection Am J Kidney Dis 37 2001 1056 1068
291. D.A. Maddox, F.K. Alavi, E.M. Silbernick, and E.T. Zawada Protective effects of a soy diet in preventing obesity-linked renal disease Kidney Int 61 2002 96 104
292. T. Sakemi, Y. Ikeda, and K. Shimazu Effect of soy protein added to casein diet on the development of glomerular injury in spontaneous hypercholesterolemic male Imai rats Am J Nephrol 22 2002 548 554
293. D.E. Fair, M.R. Ogborn, H.A. Weiler, N. Bankovic-Calic, E.P. Nitschmann, and S.C. Fitzpatrick-Wong Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats J Nutr 134 2004 1504 1507
294. J. Trujillo, V. Ramirez, J. Perez, I. Torre-Villalvazo, N. Torres, and A.R. Tovar Renal protection by soy diet in obese Zucker rats is associated with restoration of nitric oxide generation Am J Physiol Renal Physiol 2004
295. L. Azadbakht, R. Shakerhosseini, S. Atabak, M. Jamshidian, Y. Mehrabi, and A. Esmaill-Zadeh Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy Eur J Clin Nutr 57 2003 1292 1294
296. S.R. Teixeira, K.A. Tappenden, L. Carson, R. Jones, M. Prabhudesai, and W.P. Marshall Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy J Nutr 134 2004 1874 1880
297. B.M. Brenner, T.W. Meyer, and T.H. Hostetter Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease N Engl J Med 307 1982 652 659
298. S. Klahr, J. Buerkert, and M.L. Purkerson Role of dietary factors in the progression of chronic renal disease Kidney Int 24 1983 579 587
299. H. Nakamura, M. Takasawa, S. Kashara, A. Tsuda, T. Momotsu, and S. Ito Effects of acute protein loads of different sources on renal function of patients with diabetic nephropathy Tohoku J Exp Med 159 1989 153 162
300. P. Kontessis, S. Jones, R. Dodds, R. Trevisan, R. Nosadini, and P. Fioretto Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins Kidney Int 38 1990 136 144
301. J.W. Anderson, B.M. Smith, and C.S. Washnock Cardiovascular and renal benefits of dry bean and soybean intake Am J Clin Nutr 70 1999 464S 474S
302. D. Fouque, M. Laville, J.P. Boissel, R. Chifflet, M. Labeeuw, and P.Y. Zech Controlled low protein diets in chronic renal insufficiency: meta-analysis BMJ 304 1992 216 220
303. M.T. Pedrini, A.S. Levey, J. Lau, T.C. Chalmers, and P.H. Wang The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis Ann Intern Med 124 1996 627 632
304. M.M. Jibani, L.L. Bloodworth, E. Foden, K.D. Griffiths, and O.P. Galpin Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status Diabet Med 8 1991 949 953
305. G. D'Amico, and M.G. Gentile Influence of diet on lipid abnormalities in human renal disease Am J Kidney Dis 22 1993 151 157
306. G. Barsotti, E. Morelli, A. Cupisti, M. Meola, L. Dani, and S. Giovannetti A low-nitrogen low-phosphorus Vegan diet for patients with chronic renal failure Nephron 74 1996 390 394
307. N. Soroka, D.S. Silverberg, M. Greemland, Y. Birk, M. Blum, and G. Peer Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients Nephron 79 1998 173 180
308. T. Ranich, S.J. Bhathena, and M.T. Velasquez Protective effects of dietary phytoestrogens in chronic renal disease J Ren Nutr 11 2001 183 193
309. T. Sakemi, Y. Ikeda, K. Shimazu, and T. Uesugi Attenuating effect of a semipurified alcohol extract of soy protein on glomerular injury in spontaneous hypercholesterolemic male Imai rats Am J Kidney Dis 37 2001 832 837
310. J. Neugarten, A. Acharya, J. Lei, and S. Silbiger Selective estrogen receptor modulators suppress mesangial cell collagen synthesis Am J Physiol Renal Physiol 279 2000 F309 F318
311. M. Slater, D. Brown, and A. Husband In the prostatic epithelium, dietary isoflavones from red clover significantly increase estrogen receptor beta and E-cadherin expression but decrease transforming growth factor beta1 Prostate Cancer Prostatic Dis 5 2002 16 21
312. McCarty MF. Adjuvant strategies for prevention of glomerulosclerosis. Med Hypotheses 2006; in press.
313. Y. Higuchi, K. Otsu, K. Nishida, S. Hirotani, H. Nakayama, and O. Yamaguchi The small GTP-binding protein Rac1 induces cardiac myocyte hypertrophy through the activation of apoptosis signal-regulating kinase 1 and nuclear factor-kappa B J Biol Chem 278 2003 20770 20777
314. F. Simko, and J. Simko The potential role of nitric oxide in the hypertrophic growth of the left ventricle Physiol Res 49 2000 37 46
315. W.K. Lim, B. Wren, N. Jepson, S. Roy, and G. Caplan Effect of hormone replacement therapy on left ventricular hypertrophy Am J Cardiol 83 1999 1132 1134 A9
316. C.G. du, J. Ribstein, J.L. Pasquie, and A. Mimran [Determinant of left ventricular hypertrophy in the hypertensive woman. Influence of hormone replacement therapy for menopause] Arch Mal Coeur Vaiss 92 1999 975 977
317. M.G. Modena, R. Molinari, N. Muia Jr., A. Castelli, F. Pala, and R. Rossi Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women Am J Hypertens 12 1999 1000 1008
318. M.G. Modena, N. Muia Jr., P. Aveta, R. Molinari, and R. Rossi Effects of transdermal 17beta-estradiol on left ventricular anatomy and performance in hypertensive women Hypertension 34 1999 1041 1046
319. K.C. Light, A.L. Hinderliter, S.G. West, K.M. Grewen, J.F. Steege, and A. Sherwood Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women J Hypertens 19 2001 269 278
320. C.S. Hayward, C.M. Webb, and P. Collins Effect of sex hormones on cardiac mass Lancet 357 2001 1354 1356
321. Y. Miya, H. Sumino, S. Ichikawa, T. Nakamura, T. Kanda, and H. Kumakura Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women Hypertens Res 25 2002 153 159
322. E. Agabiti-Rosei, and M.L. Muiesan Left ventricular hypertrophy and heart failure in women J Hypertens 20 Suppl 2 2002 S34 S38
323. C. Grohe, S. Kahlert, K. Lobbert, M. Stimpel, R.H. Karas, and H. Vetter Cardiac myocytes and fibroblasts contain functional estrogen receptors FEBS Lett 416 1997 107 112
324. M. Skavdahl, C. Steenbergen, J. Clark, P. Myers, T. Demianenko, and L. Mao The Beta Estrogen Receptor Mediates Male-Female Differences in the Development of Pressure Overload Hypertrophy Am J Physiol Heart Circ Physiol 2004
325. C. Picherit, V. Coxam, C. Bennetau-Pelissero, S. Kati-Coulibaly, M.J. Davicco, and P. Lebecque Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats J Nutr 130 2000 1675 1681
326. H.J. Teede, B.P. McGrath, L. DeSilva, M. Cehun, A. Fassoulakis, and P.J. Nestel Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women Arterioscler Thromb Vasc Biol 23 2003 1066 1071
327. D. Fonseca, and W.E. Ward Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice Bone 35 2004 489 497
328. O.L. Woodman, M.A. Missen, and M. Boujaoude Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1 J Cardiovasc Pharmacol 44 2004 155 163
329. K.D. Setchell, N.M. Brown, and E. Lydeking-Olsen The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones J Nutr 132 2002 3577 3584
330. I.R. Rowland, H. Wiseman, T.A. Sanders, H. Adlercreutz, and E.A. Bowey Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora Nutr Cancer 36 2000 27 32
331. B. Armstrong, and R. Doll Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices Int J Cancer 15 1975 617 631
332. J.R. Hebert, T.G. Hurley, B.C. Olendzki, J. Teas, Y. Ma, and J.S. Hampl Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study [see comments] J Natl Cancer Inst 90 1998 1637 1647
333. J.R. Hebert, and A. Rosen Nutritional, socioeconomic, and reproductive factors in relation to female breast cancer mortality: findings from a cross-national study Cancer Detect Prev 20 1996 234 244
334. M.F. McCarty Mortality from Western cancers rose dramatically among African-Americans during the 20th century: are dietary animal products to blame? Med Hypotheses 57 2001 169 174
335. E. Giovannucci Nutrition, insulin, insulin-like growth factors and cancer Horm Metab Res 35 2003 694 704
336. M.F. McCarty Insulin and IGF-I as determinants of low 'Western' cancer rates in the rural third world Int J Epidemiol 33 2004 908 910
337. N.E. Allen, P.N. Appleby, G.K. Davey, R. Kaaks, S. Rinaldi, and T.J. Key The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans Cancer Epidemiol Biomarkers Prev 11 2002 1441 1448
338. B.H. Arjmandi, D.A. Khalil, B.J. Smith, E.A. Lucas, S. Juma, and M.E. Payton Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion J Clin Endocrinol Metab 88 2003 1048 1054
339. D.A. Schulsinger, M.M. Root, and T.C. Campbell Effect of dietary protein quality on development of aflatoxin B1-induced hepatic preneoplastic lesions J Natl Cancer Inst 81 1989 1241 1245
340. T.C. Campbell, and C. Junshi Diet and chronic degenerative diseases: perspectives from China Am J Clin Nutr 59 1994 1153S 1161S